d00755 0 0 0 /sys
人 民 网 版 权 所 有 ，未 经 书 面 授 权 禁 止 使 用
。Safew下载对此有专业解读
portfolio that generates sustainable annual
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
Nature, Published online: 25 February 2026; doi:10.1038/d41586-026-00515-x